iBio, a developer of plant-based biotechnology, has announced the completion of expanded product development capacity at its subsidiary, iBio CMO, jointly owned with affiliates of Eastern Capital, for the production of pharmaceutical proteins in hydroponically-grown green plants and the large-scale manufacture of biological pharmaceutical products. iBio is…
iBio Expands Development Capacity for Plant-based Fibrotic Disease Therapies
Why We Can’t Stop Raising Awareness of IPF
Most people still don’t know what idiopathic pulmonary fibrosis (IPF) is. Unfortunately, raising awareness for a disease is an ongoing process. It’s essential we keep talking about it. Here are some simple facts about idiopathic pulmonary fibrosis. In this Irish…
I’ve been going to pulmonary rehab for about two years. It takes place at a very different kind of gym. It is a pulmonary rehab gym for people who have lung conditions and who need to be monitored (oxygen levels and heart rate) while exercising.
This video from the Lung Institute, shared in June 2015, is all about how yoga may help people with chronic lung diseases such as pulmonary fibrosis or COPD breathe easier. Staying healthy when you have pulmonary fibrosis. Find out more. Yoga is a gentle exercise that focuses on…
Bristol-Myers Squibb has acquired exclusive worldwide rights to Nitto Denko’s antifibrotic drug development efforts with siRNA molecules. In addition to the Japanese company’s lead compound ND-L02-s0201, currently in a Phase 1b clinical trial (NCT02227459) for advanced liver fibrosis, the agreement gives Bristol-Myers the right to obtain licenses for other…
PFF Summit: Managing Pulmonary Fibrosis Symptoms
In this video shared by the Pulmonary Fibrosis Foundation, we see a webinar filmed at the PFF Summit: From Bench to Bedside held in Washington D.C. in November 2015. Find out more about some of the early signs of pulmonary fibrosis here. Dr. Maryl E. Kreider presents…
Australian and German companies, AdAlta and  XL-protein, have entered into a collaboration to create a long-acting form of AdAlta’s AD-114, an antibody-based treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic conditions. According to the agreement, XL-protein will contribute with their PASylation technology, attaching a string of amino acids that…
Windtree Therapeutics recently presented preclinical data supporting the potential effectiveness of its KL4 surfactant against acute and chronic lung injury and fibrosis induced by exposure to radiation. The data were presented at the 62nd Radiation Research Society (RRS) Annual Meeting, that took place in Hawaii in October. KL4 is a synthetic, peptide-containing surfactant structurally similar to the…
9 Ways to Motivate Yourself to Exercise
Exercising and keeping as fit as possible is encouraged for everyone, but especially for people with pulmonary fibrosis. Regular exercise has been shown to help pulmonary fibrosis patients, and keep stress levels low and improve sleep. Here are nine ways to motivate yourself to get out there and start exercising, based on tips…
Jordan Howard, the lead rusher for the Chicago Bears football team whose father died of pulmonary fibrosis (PF), will announced his intent to be a PF advocate and supporter of efforts to better treat and cure the disease today at the 2016 Pulmonary Fibrosis Foundation (PFF) Volunteer Meeting in Chicago. Howard’s father, Dr. Reginald…
Your PF Community
Recent Posts
- Starting the year with a vision of wellness and a plan to follow through January 15, 2026
- New trial data show oral therapy alters immune pathways in adults with IPF January 14, 2026
- When you’re an IPF patient, the costs of care add up, but help is out there January 13, 2026
- Appearances can be deceptive for those living with pulmonary fibrosis January 13, 2026
- Gut bacteria B. adolescentis may be new preventive treatment for PF January 7, 2026
